161 related articles for article (PubMed ID: 31930127)
21. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p.
Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C
Gene; 2020 Feb; 726():144145. PubMed ID: 31743769
[TBL] [Abstract][Full Text] [Related]
22. HMGN5 Silencing Suppresses Cell Biological Progression via AKT/MAPK Pathway in Human Glioblastoma Cells.
Ma Q; Wang X; Wang H; Song W; Wang Q; Wang J
Biomed Res Int; 2020; 2020():8610271. PubMed ID: 32596388
[TBL] [Abstract][Full Text] [Related]
23. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
[TBL] [Abstract][Full Text] [Related]
24. HMGN5 blockade by siRNA enhances apoptosis, suppresses invasion and increases chemosensitivity to temozolomide in meningiomas.
He J; Liu C; Wang B; Li N; Zuo G; Gao D
Int J Oncol; 2015 Oct; 47(4):1503-11. PubMed ID: 26315299
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
26. Research advances in HMGN5 and cancer.
Shi Z; Tang R; Wu D; Sun X
Tumour Biol; 2016 Feb; 37(2):1531-9. PubMed ID: 26700674
[TBL] [Abstract][Full Text] [Related]
27. HMGN5: a potential oncogene in gliomas.
Qu J; Yan R; Chen J; Xu T; Zhou J; Wang M; Chen C; Yan Y; Lu Y
J Neurooncol; 2011 Sep; 104(3):729-36. PubMed ID: 21373965
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
29. HMGN5 expression in bladder cancer tissue and its role on prognosis.
Wu J; Wang J
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):970-975. PubMed ID: 29509244
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
[TBL] [Abstract][Full Text] [Related]
31. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
[TBL] [Abstract][Full Text] [Related]
32. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway.
Liu JL; Li J; Xu JJ; Xiao F; Cui PL; Qiao ZG; Chen XD; Tao WD; Zhang XL
Mol Pharmacol; 2019 Apr; 95(4):451-461. PubMed ID: 30674565
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
Xue M; Li X; Chen W
Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
[TBL] [Abstract][Full Text] [Related]
34. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
35. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
38. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
[TBL] [Abstract][Full Text] [Related]
39. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
[TBL] [Abstract][Full Text] [Related]
40. miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.
Leng J; Song Q; Zhao Y; Wang Z
Int J Oncol; 2018 Apr; 52(4):1095-1104. PubMed ID: 29484432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]